awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q54978314-AEB9FAFF-B346-418D-9773-BA979AE91BB9
Q54978314-AEB9FAFF-B346-418D-9773-BA979AE91BB9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54978314-AEB9FAFF-B346-418D-9773-BA979AE91BB9
Combination of two anti-tubulin agents, eribulin and paclitaxel, enhances anti-tumor effects on triple-negative breast cancer through mesenchymal-epithelial transition.
P2860
Q54978314-AEB9FAFF-B346-418D-9773-BA979AE91BB9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54978314-AEB9FAFF-B346-418D-9773-BA979AE91BB9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3cf12b93b56e70cce971efc5116b924dc624d21b
P2860
Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models